Funding Received
$24 Million in 1 Round from 3 Investors
Most Recent Funding
$24 Million Series B on September 17, 2010
Eddingpharm, a specialty pharmaceuticals company, focused on clinical nutrition, oncology, antibiotics, and respiratory system therapeutics.

Company Details


Eddingpharm, headquartered in Shanghai, is a leading specialty pharmaceuticals company in the fast growing China market. The Company is focused on medical nutrition and oncology therapeutic areas and became a leading commercialization platform for pharmaceutical products in China. To date, Eddingpharm has been granted exclusive market rights of more than 16 products and achieved outstanding performance on marketed products through its 23 district offices reaching over 1000 hospitals in China. Eddingpharm has become the partner of choice for multiple global pharmaceutical companies and continues to expand further alliance opportunities with international partners. Additionally, the Company is currently building R&D and manufacturing capabilities through strategic alliances, enabling it to develop customized pipeline best fitted for Chinese healthcare market.

Funding Rounds (1) - $24M


Board Members and Advisors (1)


Investors (3)

  • 0a3acad2d1a668f5769bee7f82e0eb3a

    Domain Associates

    Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on...
  • Enipr6fqjwvvv6que6jf

    Sequoia Capital

    Venture Capital
  • B1ce9d2887c930e2d5d82b64a7eebcb9

    OrbiMed Advisors

    OrbiMed is a healthcare-dedicated investment firm, with approximately $5 billion in assets under...

Offices/Locations (1)

  • Office


    Hong Kong